VC-backed Sensei Biotherapeutics sets IPO pricing terms
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, has priced its over 5.8 million shares between $16 and $18 per share.
1 February 2021•3 mins read
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, has priced its over 5.8 million shares between $16 and $18 per share.
